Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.880
-0.030 (-1.03%)
At close: Nov 4, 2024, 4:00 PM
2.850
-0.030 (-1.04%)
Pre-market: Nov 5, 2024, 8:00 AM EST
Editas Medicine Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$10.17
Upside
+253.13%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $7 → $3 | Hold | Maintains | $7 → $3 | +4.17% | Oct 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $27 → $9 | Buy | Maintains | $27 → $9 | +212.50% | Oct 23, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $12 | Strong Buy | Maintains | $20 → $12 | +316.67% | Oct 22, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $8 | Hold | Reiterates | $8 | +177.78% | Sep 19, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +351.39% | Sep 17, 2024 |
| Barclays | Barclays | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | +143.06% | Aug 8, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $20 → $12 | Strong Buy | Maintains | $20 → $12 | +316.67% | Aug 8, 2024 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $13 → $15 | Hold → Strong Buy | Upgrades | $13 → $15 | +420.83% | Aug 8, 2024 |
| Oppenheimer | Oppenheimer | Hold Maintains $12 | Hold | Maintains | $12 | +316.67% | Jun 18, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $15 → $7 | Hold | Maintains | $15 → $7 | +143.06% | May 30, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +420.83% | May 9, 2024 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $7 | Sell → Hold | Upgrades | $7 | +143.06% | May 9, 2024 |
| Barclays | Barclays | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +212.50% | May 9, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $11 → $16 | Strong Buy | Maintains | $11 → $16 | +455.56% | Feb 29, 2024 |
| Barclays | Barclays | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | +281.94% | Feb 29, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +212.50% | Feb 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.